This report describes the production and characterization of 13 rodent monoclonal antibodies to the human erythrocyte anion transport protein AEl (syn. band 3). Eleven antibodies (4 murine and 7 rat) recognize epitopes dependent on the integrity of the third extracellular loop of the protein. TWO antibodies (1 murine and 1 rat) recognize epitopes on the Nterminal cytoplasmic domain. Quantitative binding studies using radioiodinated IgG and Fab fragments of antibodies to extracellular epitopes on AE1 ranged from 77,000 to 313,000 (IgG) and from 241,000 to 772,000 (Fab) molecules bound at saturation. The results indicate that the epitopes recognized by different antibodies vary in their accessibility and suggest HE STRUCTURE AND function of the erythrocyte anion transporter (syn. band 3, AE1) has been reviewed recently.' The protein consists of two domains. The 40-kD N-terminal domain is located entirely within the cytoplasm and forms binding sites for intracellular components including hemoglobin and the red blood cell (RBC) skeleton. The 55-kD C-terminal domain is membrane associated, terminates within the cell, and is involved in anion exchange. The complete amino acid sequence of human AE1 has been deduced from cDNA sequence2 and hydropathy analysis suggests there may be as many as 14 membrane-spanning regions. There are seven hydrophilic regions that are either located in the outer lipid layer or protrude from the cell as extracellular loops. Various methods of topographical analysis have been used in the search for a reliable structural model. Protein labeling and protease digestion of intact RBCs and "leaky" RBC membranes have been used to determine the membrane orientation and localization of individual amino acid residues and surrounding domain^.^" Such studies have been aided by the use of monoclonal antibodies (MoAbs) that bind to intracellular epitopes on AE16,7 and MoAbs that bind to exofacial polypeptide epitopes on AE1 would also be useful for this purpose.
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In addition, antibodies to the extracellular regions of AE1 would be useful tools with which to study the mechanism of anion transport, the topology of AE1 variants, and the implied roles of AEl in the invasion of RBCs by malarial parasites8 and in the removal of senescent RBCs via opsonization with autologous antibodies. ' We describe here the production and characterization of 4 mouse and 7 rat MoAbs that react with exofacial epitopes on AE1. The binding of these antibodies is shown to be dependent on the extracellular loop between the 5th and 6th membrane-spanning regions of AE1. We also describe two MoAbs (1 mouse and 1 rat) that bind to intracellular epitopes on the 40-kD N-terminal domain of AEl . Quantitative binding studies using purified radioiodinated IgG and Fab preparations of the antibodies against extracellular epitopes provide evidence that structural heterogeneity exists between AE1 molecules on RBCs and show that some epitopes are altered on the mutant AE1 found in RBCs from individuals with South East Asian ovalocytosis (SAO). The treatments of RBCs with pronase, trypsin, chymotrypsin." sialidase,'" and aminoethylisothiouronium bromide (AET)" were as described. The treatment of RBCs with N-tosyl-L-phenyl alaninechloromethylketone (TPCK)-treated trypsin under low ionic strength (LISS) conditions was as described." RBCs were also treated sequentially with Chymotrypsin and then LISS trypsin. Standard serologic techniques were used and polyspecific rabbit antimouse or antirat Ig was used for indirect agglutination tests (DAKO Ltd. High Wycombe, UK). RBC membranes were prepared by lysing RBCs in S mmoliL or 7 mrnoln phosphate buffer at 4°C. The trypsin treatment and NaOH stripping of leaky RBC membranes was performed as described: except that TPCK-treated trypsin and phenylmethylsulfonylfluoride (PMSF) inhibitor were used.
MATERIALS AND METHODS

Normal
Immunoprecipitation from radioiodinated or unlabeled RBCs and cultured cell lines was essentially as previously described."' except that membranes were solubilized with 2% wt/vol Triton X-100; protein G Sepharose (Pharmacia Ltd. Milton Keynes, UK) was used with BRlCs 71, 90, and 200 and BRACs IS, 18, 21, 23, and 25; and rabbit antirat Ig (DAKO Ltd) was used with BRACs 14 and 17. Immune complexes were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and visualized by autoradiography or by immunoblotting with murine antibodies reactive with the intracellular N-and C-termini of AEI, BRIC 169 (described here), or BRlC 130: SDS-PAGE and immunoblotting were as described," except that S 8 wt/vol bovine milk powder was used as the blocking agent, Immohilon-P membranes were used, and rabbit antirat peroxidase conjugate (DAKO Ltd) was used with the rat antibodies.
The purification of BRlCs 6.71.90. and 200 and BRAG 14 and 17 was performed on protein A Sepharose and BRACs I S, 18. 2 1, 23. and 25 on protein G Sepharose, following the manufacturers' methods. Size exclusion chromatography was performed using a G3000SW, TSK column (Anachem Ltd. Luton. UK). Purification of Fab fragments, radioiodination of whole IgG and Fah fragments and their use in quantitative binding, and functional affinity and competitive inhibition assays were as previously described in detail.'' Indirect immunofluorescence using myeloid (HL60 and U937). lymphoid (RAJI. DAUDI, and MOLT4). and erythroid (HEL and KS62) cells lines and normal peripheral blood cells (lymphocytes, granulocytes. and platelets) was performed using a fluorescenceactivated cell sorter (FACStar; Becton Dickinson, Oxford, UK).
RESULTS
Initial characterization of MoAhs to intracellular epitopes on AEI.
BRlC 169 and BRAC 66 did not agglutinate human RBCs but reacted by immunoblotting with a broad band migrating with leading edge of 95 kD (Fig I , lanes a and  d) . This band was identical to that obtained with BRlC 130 (Fig I , lane g ), a previously described murine MoAb that binds to the intracellular C terminus of AE1.h AEI on intact cells is cleaved by chymotrypsin into 60-kD (N-terminal) and 35-kD (C-terminal) fragments.'."' BRIC 169 and BRAC 66 bound to the 60-kD chymotryptic fragment (Fig 1, lanes  b and e) , whereas BRIC 130 bound to the 35-kD fragment (Fig I , lane h) . Trypsin treatment of whole RBCs under normal ionic strength conditions does not noticeably affect AEI, but the gentle trypsin treatment of unsealed membranes, as described in the Materials and Methods, cleaves AEI at Lys360," giving rise to a 55-kD membrane-bound fragment and releasing a 40-kD N-terminal fragment. BRlC 130 detected the 55-kD tryptic fragment (Fig 1, lane i) , but BRlC 169 and BRAC 66 did not (Fig I , lanes c and f) . These results suggest that BRlC 169 and BRAC 66 bind to epitopes located on the cytoplasmic 40-kD N-terminal tryptic fragment of AEI.
Initial characterization cf MoAhs to extracellular epitopes
on AEI. Serologic properties of the four murine and seven rat MoAbs to exofacial epitopes on AEI are given in Table  1 Table  I) Fig 2, lanes e and f) . Confirmation that the band was identical to AE1 was obtained by immunoblotting the electrophoretically separated components of immune precipitates with AEI-specific murine MoAbs BRIC 130 (Fig 2, lanes k through p) and BRIC 169 (data not shown).
AE1 is a member of a family of proteins that have highly homologous membrane domains. AE1 is restricted to RBCs and certain cells in the kidney,'j whereas nonerythroid anion exchange proteins (AE2 and AE3) are present in a wide variety of cells and tissues." Four of the rat antibodies (BRACs 17, 18,21, and 23) reacted by immune fluorescence with normal peripheral blood granulocytes and the myeloid cell lines, HL60 and U937 (data not shown). Murine BRIC 6 reacted weakly with U937 cells. The reactive antibodies no longer bound to U937 cells when Fc receptors were blocked by preincubation with human serum before reactivity with the MoAbs. In studies using radioiodinated U937 cells, BRACs 18, 21, and 23 immuneprecipitated a broad radioiodinated band with a leading edge of 70 kD after SDS-PAGE under reducing conditions (data not shown).
Quantitation of the number of molecules of monoclonal anti-AEl bound to normal RBCs at saturation and determination of affinity constants. Radioiodinated IgG and Fab fragments, prepared from the 1 1 antibodies reactive with extracellular AE 1 epitopes, were used in quantitative binding assays. The number of epitopes recognized by each antibody was calculated from the maximum number of radioiodinated IgG molecules or Fab fragments bound per RBC at saturation (Scatchard analysis; Fig 3 and Table 2 ). The number of IgG molecules bound ranged from 77,000 to 313,000 and for Fab fragments from 241,000 to 772,000 (Table 2) . Functional affinity constants were determined from Karush plots," as previously described" (Fig 3 and Table 2 ). The affinity constants for IgG were between 4 and 35 times greater than those of Fab fragments. Table 4) . Binding of anti-AEls was also compared with anti-W8' (BRIC 14) and anti-GPA (R18). Reduced binding of anti-Wrb was observed (79% of normal), whereas the results obtained for R18 were not significantly different between normal and S A 0 cells (Table 4) .
For Only BRIC 6 (IgG3) and BRAC 14 (IgG1) agglutinated untreated RBCs directly. These isotypes do not have unusually long and/or flexible hinge regions26327 and so it might be expected that the distance between AE1 proteins on different RBCs would be too great for monomeric BRIC 6 or BRAC 14 to span. However, dimers or higher oligomers of BRIC 6 or BRAC 14 were not found when purified antibody preparations were subjected to size exclusion chromatography 2933 (data not shown). There is some evidence that mouse IgG3 forms noncovalent dimers via Fc-Fc interactions when antibody binding occurs. 28 It is possible that BRIC 6 agglutinates RBCs through this mechanism and that rat IgGl (BRAC 14) may interact in a similar manner.
Immunofluorescence experiments showed that BRACs 17, 18,21, and 23 and BRIC 6 bind to myeloid cells and BRACs 18, 21, and 23 were shown to immune precipitate a component of 70 kD from U937 cells. It seems likely that these antibodies were binding via their Fc domains and precipitating Fc receptor I (FcRI) known to be present on U937 cells.29 This conclusion is supported by the observation that human Abbreviations: +, greater than 50% inhibition; (+), 10% to 50% inhibition; -, less than 10% inhibition; ND, not determined.
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serum inhibited the binding of MoAbs to U937 cells. BRACs 17, 18, 21, and 23 are IgG2b, the only rat isotype that contains the Leu-Leu-Gly-Gly-Pro motif (aa 234 to 238)27 believed to be essential for human FcRI interaction."' Mouse IgG3 (BRIC 6) also binds weakly to human FcR1.j' Granulocytes do not express FcRI, but they do express FcRIII, a medium-affinity receptor that binds human IgGI and IgG3," the isotypes most similar to rat IgG2b'': this may explain why the rat antibodies bound to granulocytes.
Quantitation of the number of anti-AEl molecules bound to RBCs ut snturation. The number of molecules of AEI on normal RBCs is estimated to be of the order of IOh / cell.*" The results obtained with anti-AEl showed that the number of binding sites/RBC were generally lower for IgG than for Fab fragments of the same antibody ( Table 2 ). These differences are probably attributable to steric hindrance, which prevents access of the larger IgG molecules to all available epitopes. We have noticed that site numbers determined with some MoAbs may vary when different preparations of the antibodies are labeled with different "' 1 preparations; therefore, results obtained with a single labeled antibody preparation should be treated with caution. The data for BRIC 6, BRAC 17, and BRAC 25 presented in Table 2 were obtained from several different antibody preparations (4, 3, and 2, respectively) and several different radioiodinations (6, 3, and 4, respectively) and the results were reproducible for each antibody. The data show considerable variation in the number of epitopes accessible to IgG or Fab fragments prepared from different anti-AEls. We have previously observed a similar wide range of values with preparations from different monoclonal anti-GPAs, but in this case the variation could be explained, at least in part. by heterogeneity of 0-glycosylation on this glycoprotein." AEI does not possess 0-glycans and the single N-glycan does not appear to be a prerequisite for binding of antibodies described here because HEMPAS cells, which have a truncated N-glycan on AEI," and En(a-) or MkMLcells, which have an abnormally large N-glycan on AEl,2"75 both give normal reactions with anti-AEIs. Our results suggest that there is some heterogeneity in the organization of individual AEI molecules in the RBC membrane such that certain epitopes are not accessible on all molecules. It is possible that fatty acylation could influence the organization of different AEI molecules in normal cells." Alternatively, and perhaps more likely, the accessibility of epitopes on AEI may be influenced by the oligomeric state of the protein. Approximately 70% of the AEI in normal RBCs is in the form of a dimer, with the remainder consisting of tetramer and higher oligomers. The proportion of tetramer and higher oligomers increases with RBC age (22% in young cells and 56% in old cellsj7). It is possible that those antibodies giving unexpectedly low numbers of AEl binding sites (Fab fragments of BRAC 1 5, 2 I , and 25; Table 2 ) preferentially recognize tetrameric AEl. If this is so, then it might be anticipated that old RBCs would have a higher number of binding sites for these antibodies than young RBCs. Experiments designed to address this possibility are in progress.
Epitope mapping of monoclonal anti-AEIs. The results of competitive inhibition experiments suggest that the anti-AE I s recognize a heterogeneous group of related epitopes ( Table 3 ). All of these epitopes depend on the integrity of the third extracellular loop of AEl because all are lost after chymotrypsin treatment or a combination of chymotrypsin and trypsin treatment under low ionic strength conditions (vide supra).
Interpretation of these data is complicated by the possibility discussed above that antibody binding is influenced by the oligomeric state of AEI in the RBC membrane. Nevertheless, it is interesting to note that some anti-AEI S, notably BRIC 6, can impede the binding of anti-Wrh (Table 3) . The Wrh epitope is defined by interaction between AE1 and GPA and is dependent on GLU 658 in the fourth extracellular loop of AEI ." Altered e.wpression o j A E l epitopes on SAO. Several recent studies of S A 0 have shown that the phenotype results from inheritance of an abnormal form of AEI that lacks 9 amino acids (400-408)3y~"" at the junction of the N-terminal cytoplasmic domain and the first transmembrane domain. This abnormal AEI (AEI SAO), which has only been described in heterozygotes, is thought to confer some protection against malarial parasitemia.4' It is presumed that homozygosity for AEI S A 0 would be a lethal condition because AEI S A 0 does not function as an anion tran~porter.'~.~' SA0 RBCs are more rigid than normal RBCs and this has been related to the observation that AEI S A 0 has a higher tetramerdimer ratio than normal AEI (50% compared with
The reduction in binding of BRIC 6 and BRAC 25 to S A 0 cells (Table 4) appears too large to be accounted for by alterations i n the dimer:tetramer ratio of AEl on these cells. Because the antibodies to extracellular AEI each recognize epitopes that depend on the integrity of the third extracellular loop of normal AE1 (vide supra), the reduced number of BRIC 6 and BRAC 25 epitopes found in the binding studies with S A 0 RBCs suggest that subtle changes in the folding of this loop occur in AEI SAO.
The anion transport inhibitor di-isothiocyanato-dihydrostilbene disulphonate (H2DIDS) fails to bind AEI SAO."' The H,DIDS binding site is located in the fifth transmembrane domain at Lys-539 or Lys-542.' Therefore, it is possible that the changes in the folding of AEI S A 0 that give rise to the loss of the H,DIDS binding site also alter the accessibility of the BRIC 6 and BRAC 25 epitopes. At alkaline pH, H2DIDS cross-links Lys539 with Lys851, +!" which is predicted to be between transmembrane domains 13 and 14 on extracellular loop 7. The Di" blood group antigen is associated with increased binding of H2D1DS4' and has recently been shown to correlate with a Pro854-Leu change also on the 7th extracellular loop of AEI. 46 In this context it is interesting to note that the Dib antigen is reported to be severely depressed in S A 0 cells.47 These and other results"' suggest that changes in the extracellular region between transmembrane domains 13 and 14 and in transmembrane domain 14 itself can modify the environment of Lys-539.
There are other abnormalities associated with S A 0 cells. Weakened reactions of the polyclonal antibodies made by En(a-) individuals (anti-GPA and anti-Wrb' have been re~o r t e d .~' Our results (Table 4) confirm previous observa-
30%).4'
For personal use only. on November 11, 2017 . by guest www.bloodjournal.org From tions4' that the number of Wrb antigen sites is significantly reduced on SA0 cells, although the results for GPA are less conclusive (GPA site numbers were only marginally reduced on some SA0 cells).
Taken together, these results suggest that the mutation that gives rise to the deletion of residues 400-408 at the junction of the N-terminal cytoplasmic domain with the first transmembrane domain of AEl affects the accessibility of antigens associated with extracellular loops formed by the 5th/6th (BFUC 6), 7W8th (W?), and 13tW14th (Dib) transmembrane regions. Such a conclusion is consistent with other that conclude that a highly cooperative interaction exists between transmembrane domains in AEl such that a change in one domain can disrupt its interaction with others. These interactions between apparently remote regions of AE1 may occur if AE1 adopts a circular or helical conformation in addition to forming oligomers in the RBC membrane.
The evidence presented by Booth et a14' suggests that the abnormalities found in SA0 cells are not confined to AEl. In particular, they note weakened expression of Rh antigens and other antigens located on proteins now known to be associated with Rh (LW, S, S, and U). Preliminary studies on S A 0 cells using MoAb BRIC 69, which binds to the Rh 30-kD polypeptides," show a 33% reduction in the site numbers found on SA0 cells in comparison with normal (data not shown), suggesting that the Rh polypeptides may be intimately associated with AE1 in these cells. These resufts raise the interesting possibility that AEI is closely associated with other integral membrane proteins (in addition to GPA) in the normal RBC and that the mutation in AE1 SA0 also effects changes in the organization of these proteins on SA0 cells. The S and S antigens are on glycophorin B (GPB) and, because GPB forms heterodimers with GPA that are stable under the conditions of SDS-PAGE," a large membrane complex comprising AEl, GPA, GPB, and Rh proteins seems possible.
